Kevin Otipoby

Seismic Therapeutic

Poster(s):

• W121 - Preclinical Pharmacology of S-1117, a Novel Engineered Fc-fused IgG Cleaving Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases
  Wednesday, June 19, 2024

  7:30 AM – 7:30 PM PT